Literature DB >> 34263580

Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study.

Daniele G Biasucci1, Danilo Buonsenso2, Alfonso Piano3, Nicola Bonadia4, Joel Vargas5, Donatella Settanni5, Maria G Bocci5, Domenico L Grieco5, Annamaria Carnicelli4, Giancarlo Scoppettuolo6, Davide Eleuteri5, Gennaro DE Pascale5, Mariano A Pennisi7, Francesco Franceschi4, Massimo Antonelli5.   

Abstract

BACKGROUND: The aim of this study is to determine relationships between lung aeration assessed by lung ultrasound (LUS) with non-invasive ventilation (NIMV) outcome, intensive care unit (ICU) admission and mechanical ventilation (MV) needs in COVID-19 respiratory failure.
METHODS: A cohort of adult patients with COVID-19 respiratory failure underwent LUS during initial assessment. A simplified LUS protocol consisting in scanning six areas, three for each side, was adopted. A score from 0 to 3 was assigned to each area. Comprehensive LUS score (LUSsc) was calculated as the sum of the score in all areas. LUSsc, the amount of involved sonographic lung areas (LUSq), the number of lung quadrants radiographically infiltrated and the degree of oxygenation impairment at admission (SpO<inf>2</inf>/FiO2 ratio) were compared to NIMV Outcome, MV needs and ICU admission.
RESULTS: Among 85 patients prospectively included in the analysis, 49 of 61 needed MV. LUSsc and LUSq were higher in patients who required MV (median 12 [IQR 8-14] and median 6 [IQR 4-6], respectively) than in those who did not (6 [IQR 2-9] and 3 [IQR 1-5], respectively), both P<0.001. NIMV trial failed in 26 patients out 36. LUSsc and LUSq were significantly higher in patients who failed NIMV than in those who did not. From ROC analysis, LUSsc ≥12 and LUSq ≥5 gave the best cut-off values for NIMV failure prediction (AUC=0.95, 95%CI 0.83-0.99 and AUC=0.81, 95% CI 0.65-0.91, respectively).
CONCLUSIONS: Our data suggest LUS as a possible tool for identifying patients who are likely to require MV and ICU admission or to fail a NIMV trial.

Entities:  

Mesh:

Year:  2021        PMID: 34263580     DOI: 10.23736/S0375-9393.21.15188-0

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  4 in total

1.  Lung Ultrasound as a First-Line Test in the Evaluation of Post-COVID-19 Pulmonary Sequelae.

Authors:  David Clofent; Eva Polverino; Almudena Felipe; Galo Granados; Marta Arjona-Peris; Jordi Andreu; Ana L Sánchez-Martínez; Diego Varona; Laura Cabanzo; Jose M Escudero; Antonio Álvarez; Karina Loor; Xavier Muñoz; Mario Culebras
Journal:  Front Med (Lausanne)       Date:  2022-01-13

2.  Lung Ultrasound in Adults and Children with COVID-19: From First Discoveries to Recent Advances.

Authors:  Danilo Buonsenso; Luigi Vetrugno
Journal:  J Clin Med       Date:  2022-07-26       Impact factor: 4.964

3.  Thromboelastography Profile Is Associated with Lung Aeration Assessed by Point-of-Care Ultrasound in COVID-19 Critically Ill Patients: An Observational Retrospective Study.

Authors:  Daniele Guerino Biasucci; Maria Grazia Bocci; Danilo Buonsenso; Luca Pisapia; Ludovica Maria Consalvo; Joel Vargas; Domenico Luca Grieco; Gennaro De Pascale; Massimo Antonelli
Journal:  Healthcare (Basel)       Date:  2022-06-22

Review 4.  Current Advances in Lung Ultrasound in COVID-19 Critically Ill Patients: A Narrative Review.

Authors:  Minh Pierre Lê; Mathieu Jozwiak; Driss Laghlam
Journal:  J Clin Med       Date:  2022-08-26       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.